MKRN2 and non-small cell lung carcinoma: Specifically, we found that MKRN2 altered PI3Kp85α ubiquitination in NSCLC cells and promoted the ubiquitin-dependent degradation of PI3Kp85α, resulting in reduced activation of the Akt pathway and stimulation of downstream gene transcription.